Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 115

Similar articles for PubMed (Select 15308738)

1.
4.

Identification of complement regulatory domains in vaccinia virus complement control protein.

Mullick J, Bernet J, Panse Y, Hallihosur S, Singh AK, Sahu A.

J Virol. 2005 Oct;79(19):12382-93.

5.

Identification of hot spots in the variola virus complement inhibitor (SPICE) for human complement regulation.

Yadav VN, Pyaram K, Mullick J, Sahu A.

J Virol. 2008 Apr;82(7):3283-94. doi: 10.1128/JVI.01935-07. Epub 2008 Jan 23.

6.

Domain swapping reveals complement control protein modules critical for imparting cofactor and decay-accelerating activities in vaccinia virus complement control protein.

Ahmad M, Raut S, Pyaram K, Kamble A, Mullick J, Sahu A.

J Immunol. 2010 Nov 15;185(10):6128-37. doi: 10.4049/jimmunol.1001617. Epub 2010 Oct 18.

7.

Mapping of regions within the vaccinia virus complement control protein involved in dose-dependent binding to key complement components and heparin using surface plasmon resonance.

Smith SA, Sreenivasan R, Krishnasamy G, Judge KW, Murthy KH, Arjunwadkar SJ, Pugh DR, Kotwal GJ.

Biochim Biophys Acta. 2003 Aug 21;1650(1-2):30-9.

PMID:
12922167
8.

Structure of vaccinia complement protein in complex with heparin and potential implications for complement regulation.

Ganesh VK, Smith SA, Kotwal GJ, Murthy KH.

Proc Natl Acad Sci U S A. 2004 Jun 15;101(24):8924-9. Epub 2004 Jun 3.

9.

Regulation of complement activity by vaccinia virus complement-control protein.

McKenzie R, Kotwal GJ, Moss B, Hammer CH, Frank MM.

J Infect Dis. 1992 Dec;166(6):1245-50.

PMID:
1431243
10.

Mapping of the sites responsible for factor I-cofactor activity for cleavage of C3b and C4b on human C4b-binding protein (C4bp) by deletion mutagenesis.

Fukui A, Yuasa-Nakagawa T, Murakami Y, Funami K, Kishi N, Matsuda T, Fujita T, Seya T, Nagasawa S.

J Biochem. 2002 Nov;132(5):719-28.

11.

Role of membrane cofactor protein (CD46) in regulation of C4b and C3b deposited on cells.

Barilla-LaBarca ML, Liszewski MK, Lambris JD, Hourcade D, Atkinson JP.

J Immunol. 2002 Jun 15;168(12):6298-304.

12.

Structure and regulatory profile of the monkeypox inhibitor of complement: comparison to homologs in vaccinia and variola and evidence for dimer formation.

Liszewski MK, Leung MK, Hauhart R, Buller RM, Bertram P, Wang X, Rosengard AM, Kotwal GJ, Atkinson JP.

J Immunol. 2006 Mar 15;176(6):3725-34.

13.

Diversity of sites for measles virus binding and for inactivation of complement C3b and C4b on membrane cofactor protein CD46.

Iwata K, Seya T, Yanagi Y, Pesando JM, Johnson PM, Okabe M, Ueda S, Ariga H, Nagasawa S.

J Biol Chem. 1995 Jun 23;270(25):15148-52.

14.

Disabling complement regulatory activities of vaccinia virus complement control protein reduces vaccinia virus pathogenicity.

Bernet J, Ahmad M, Mullick J, Panse Y, Singh AK, Parab PB, Sahu A.

Vaccine. 2011 Oct 6;29(43):7435-43. doi: 10.1016/j.vaccine.2011.07.062. Epub 2011 Jul 29.

15.

Functional characterization of soluble and membrane-bound forms of vaccinia virus complement control protein (VCP).

Rosengard AM, Alonso LC, Korb LC, Baldwin WM 3rd, Sanfilippo F, Turka LA, Ahearn JM.

Mol Immunol. 1999 Jul;36(10):685-97.

PMID:
10509819
16.

Mutations in alpha-chain of C4BP that selectively affect its factor I cofactor function.

Blom AM, Villoutreix BO, Dahlb├Ąck B.

J Biol Chem. 2003 Oct 31;278(44):43437-42. Epub 2003 Jul 31.

17.
18.
19.

Localization of the covalent C3b-binding site on C4b within the complement classical pathway C5 convertase, C4b2a3b.

Kozono H, Kinoshita T, Kim YU, Takata-Kozono Y, Tsunasawa S, Sakiyama F, Takeda J, Hong K, Inoue K.

J Biol Chem. 1990 Aug 25;265(24):14444-9.

20.

Effects of zinc on factor I cofactor activity of C4b-binding protein and factor H.

Blom AM, Kask L, Ramesh B, Hillarp A.

Arch Biochem Biophys. 2003 Oct 15;418(2):108-18.

PMID:
14522582
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk